NASDAQ: LINLinde PLC Stock
$401.27+2.62 (+0.66%)
Updated Dec 8, 2023
LIN Price
$401.27
Fair Value Price
N/A
Market Cap
$194.57B
52 Week Low
$302.17
52 Week High
$416.19
P/E
32.89x
P/B
5x
P/S
5.59x
PEG
4.65x
Dividend Yield
0.32%
Revenue
$32.45B
Earnings
$5.98B
Gross Margin
46.1%
Operating Margin
24.3%
Profit Margin
18.4%
Debt to Equity
0.97
Operating Cash Flow
$9B
Beta
0.94
Next Earnings
Feb 7, 2024
Ex-Dividend
Dec 1, 2023
Next Dividend
Dec 18, 2023
LIN Overview
Linde plc operates as an industrial gas company in North and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers oxygen, nitrogen, argon, rare gases, carbon monoxide, carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene. It also designs and constructs turnkey process plants, such as olefin, natural gas, air separation, and hydrogen and synthesis gas plants. The company serves healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, and water treatment industries. Linde plc was founded in 1879 and is based in Guildford, the United Kingdom.
Zen Score
–
Industry Average (39)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LIN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LIN ($401.27) is trading above its intrinsic value of $94.62, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LIN is poor value based on its earnings relative to its share price (32.89x), compared to the US market average (31.32x)
P/E vs Market Valuation
LIN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more LIN due diligence checks available for Premium users.
Be the first to know about important LIN news, forecast changes, insider trades & much more!
LIN News
Valuation
LIN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
32.89x
Industry
59.4x
Market
31.32x
LIN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LIN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
LIN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5x
Industry
3.18x
LIN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LIN price to earnings growth (PEG)
For valuing profitable companies with growth potential
LIN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
LIN's financial health
Profit margin
Revenue
$8.2B
Net Income
$1.6B
Profit Margin
19.2%
LIN's Earnings (EBIT) of $7.89B... subscribe to Premium to read more.
Interest Coverage Financials
LIN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$77.8B
Liabilities
$37.6B
Debt to equity
0.97
LIN's short-term liabilities ($14.16B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LIN's long-term liabilities ($23.43B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LIN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LIN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$2.5B
Investing
-$946.0M
Financing
-$964.0M
LIN's operating cash flow ($8.67B)... subscribe to Premium to read more.
Debt Coverage Financials
LIN vs Specialty Chemical Stocks
Linde Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.